| |
 |
 |
 |
 |
 |
 |
 |
 |
|
| HOME
> About Us > Alliances |
|
|
|
As a global leader in genetic medicine, we are involved in the promising
development areas, in line with our corporate philosophy: technologies
and patents from which the development of drugs originates. We have
formed the following strategic alliances to introduce several promising
development areas from universities:
| Ishihara
Sangyo Kaisha, Ltd. |
 |
| Cooperating with us in the manufacture and sale
of reagents with the use of HVJ envelope vectors. Ishihara Sangyo
Kaisha sells high-efficiency transfection kit GenomONE(R). |
| Daiichi Sankyo
Co., Ltd. |
|
| Cooperating with us in development of HGF genetic
medicine in the fields of peripheral arterial disease (PAD)
and Ischemic heart disease (IHD) both in Japan, USA and Europe.
|
 For
details, see the news release. |
| Alfresa
Pharma Corporation. |
|
Cooperating with AnGes MG on the development of
NF B
decoy oligo nucleotides in the field of atopic dermatitis. |
| For
details, see the news release. |
 |
|
 |
| |
The Group is accumulating
various know-how in the field of genetic medicine. If you are
a researcher, with original ideas and agree to the Group's policies,
we welcome your inquiries by all means. |
|
 |
|
 |
|
|
